Cargando…
Increasing the performance of pooled CRISPR–Cas9 drop-out screening
Components of the type II CRISPR–Cas complex in bacteria have been used successfully in eukaryotic cells to facilitate rapid and accurate cell line engineering, animal model generation and functional genomic screens. Such developments are providing new opportunities for drug target identification an...
Autores principales: | Cross, Benedict C. S., Lawo, Steffen, Archer, Caroline R., Hunt, Jessica R., Yarker, Joanne L., Riccombeni, Alessandro, Little, Annette S., McCarthy, Nicola J., Moore, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992892/ https://www.ncbi.nlm.nih.gov/pubmed/27545104 http://dx.doi.org/10.1038/srep31782 |
Ejemplares similares
-
Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance
por: le Sage, Carlos, et al.
Publicado: (2017) -
CRISPR: A Screener’s Guide
por: le Sage, Carlos, et al.
Publicado: (2019) -
A Flexible, Pooled CRISPR Library for Drug Development Screens
por: Blanck, Maximilian, et al.
Publicado: (2020) -
CRISPR/Cas-based customization of pooled CRISPR libraries
por: Kweon, Jiyeon, et al.
Publicado: (2018) -
CRISPR-Cas Technology In and Out of the Classroom
por: Dahlberg, Lina, et al.
Publicado: (2018)